Interestingly, the pharmacological reactivation of mutant p53 by small molecules (PRIMA, MIRA-1 and Cisplatin) showed antitumor activity in colon cancer and other human tumors103–110. This evidence concerns the gene TP53 and malignant colon neoplasm.